This study compares 12 month clinical outcomes and procedural costs at two interventional centres with significant differences in crude mortality and revascularization outcomes between 1997 and 1998. Percutaneous coronary intervention (PCI) registry data on 1046 consecutive patients treated contemporaneously at two university centres were linked to hospital discharge and death data to provide 12 month follow-up information on survival and repeat revascularization. Costs were determined by detailed analysis of equipment use, length of stay and staff from 100 contemporary cases at each centre to derive a procedural cost model. This model was then applied retrospectively to estimate cost per procedure. Stents were used more frequently at one centre (56 versus 26 per cent, 2 test, p < 0.001) resulting in greater procedural cost [mean (SE), £1970 (34) versus £1521 (39), t-test, p < 0.001). One year repeat target vessel PCI was significantly greater at the centre using more stents (10.3 versus 5.6 per cent, 2 test, p ϭ 0.005) and the need for any repeat revascularization (PCI or coronary artery by-pass surgery) was also significantly greater at this centre (18.4 versus 10.8 per cent, 2 test, p < 0.001). Cox regression revealed that after correction for case-mix the difference in the need for repeat target vessel PCI between the two centres was no longer significant (p ϭ 0.15). In the two centres studied, crude differences in cost per case, mortality and the need for revascularization were largely accounted for by significant differences in case-mix. Comparison of outcomes and costs between centres should not be published without careful adjustment for differences in case-mix.
Introduction
The use of percutaneous coronary intervention (PCI) varies greatly from country to country and from centre to centre resulting in differences in clinical outcome for patients with coronary heart disease. 1, 2 Differences in outcome may become increasingly important to clinicians if details are released into the public domain linked to the individual centres and interventionist. 3 The trend to increase the dissemination of reports to the public containing crude outcomes is a key part of government policy in the United Kingdom 4 and in the United States. Crude outcome reports comparing hospitals have already been published. 5 Release of this information to the public could have detrimental effects, including loss of public confidence, heightened competition between centres and added stress to interventionists involved. 6, 7 It is therefore vitally important that interventional centres collect detailed clinical information to allow careful casemix-adjusted analysis of outcomes. The importance of this type of analysis is that it allows a fairer comparison of outcomes between centres [8] [9] [10] and facilitates more meaningful financial planning of healthcare services. 11 This study has examined case-mix-adjusted outcomes of PCI in unselected patients in two centres which were identified as having significantly different rates of stent implantation, crude mortality and the need for repeat revascularization during the period 1997-1998. Procedure-related costs have also been analysed as these are recognized to represent an important component of performance and efficiency. 3 Comparing performance between coronary intervention centres requires detailed case-mix adjusted analysis
Materials and methods

Patient data
One thousand and forty-six patients with a PCI procedure between 1 February 1997 and 31 May 1998 were included in the analysis. Data were recorded prospectively at each centre in an Access© database (Minerva©) as part of the Scottish PCI Register. Data fields included treatment centre, patient demographics, procedure urgency cardiovascular risk factors, comorbid conditions, disease severity, left ventricular function, vessel diameter and number of stents deployed. Angina severity was defined using the Canadian Cardiovascular Society (CCS) angina score. 12 The study protocol was reviewed by the ethics committees at each centre.
Interventional centre details
The two centres studied are university teaching hospitals. The total number of annual interventional procedures was consistently greater at centre B for the 2 years before and after the period of study [mean (SD), 596 (66) versus 400 (35)]. The number of interventional cardiologists is similar at each of the centres (five at centre A, four at centre B).
Main cost drivers of PCI
Detailed prospective analysis of 100 consecutive cases in October and November 2000 at each centre was used to assess the main cost drivers for PCI. For these 200 cases the following information was recorded: equipment use (wires, balloons, guide catheters, stents), catheter laboratory time, staff present in the catheter laboratory during the procedure, volume of radiological contrast, use of drugs and number of bed-days.
Equipment costs for the study period
For the period February 1997 to May 1998, the costs of stents, balloons, wires, guides, standard equipment, standard medication, contrast and staff costs were obtained at each centre from hospital administration and finance departments. The cost of one day's hospital stay was obtained from Scottish Health Service Costs (year ended 31 March 1999). 13 The costs were averaged across the two centres so the same 'standard' cost was applied to each centre. The primary aim of this study was to assess procedure-related costs. Capital costs are not included in the analysis because these are not generally accepted to be of direct relevance to procedural cost in economic analysis. Furthermore, capital costs are often dependent on local factors unrelated to the mechanism of delivery of healthcare services.
Applying the costs retrospectively
The number of stents used for each centre was obtained from the Scottish PCI Register. Length of stay was obtained from the Scottish Morbidity Record 1 (SMR1) data collected by the Information and Statistics Division (ISD) of the Common Services Agency. SMR1 data are collected routinely on all patients admitted to all hospitals in Scotland. A fixed cost was used for the remaining items (but differed between centre depending on average wire and catheter use). Cost per procedure was then calculated using the fixed cost added to the three main cost drivers, number of stents, bed-days and balloons, to calculate the cost of an individual procedure ( Table 1) . Capital costs of equipment and buildings were assumed to be similar at the two sites and so are not included in the calculations.
Outcomes of PCI
The main outcomes assessed were repeat target vessel PCI, any revascularization, coronary artery bypass surgery (CABG) and death up to the end of May 1999. The outcome data were collected via internal linkage of records within the PCI register and from linkage of the register to SMR1 hospital records and General Registrar death data. SMR1 data are collected on all admissions to Scottish NHS hospitals and record procedure codes using the International Classification of Disease, version 10 (ICD10) classification. The General Registrar for Scotland records all deaths which occur in Scotland whether in hospital or in the community. Target vessel revascularization was calculated using data from the PCI registry examining for repeat procedures on the same vessel.
Statistical analysis
PCI procedures were compared between the two centres, in terms of case-mix and outcome, using 2 test, 2 test for trend, the t-test and the Mann-Whitney U test. This latter test was used to compare the number of stents used and duration of hospital stay, but means are presented as they are more meaningful than medians in economic analyses. Stepwise Cox proportional hazards regression was used to determine factors that 
Results
Patient characteristics (Table 2)
The 601 patients at centre B were significantly older than the 445 patients in centre A [mean (SE): 60.4 (0.43) versus 58.0 (0.43) years, t-test p < 0.001]. Patients at centre B had characteristics which suggested a more adverse cardiovascular risk profile and more severe coronary disease. Patients at centre B were also more likely to have had a previous myocardial infarction (48 versus 34 per cent, p < 0.001) and this is reflected in a greater proportion with moderate or severe left ventricular impairment (15 versus 7 per cent, p ϭ 0.005). Patients at centre A were more deprived (Carstairs deprivation category, p < 0.001) but there was no difference in smoking status (p ϭ 0.73). There were no significant differences in the proportion of patients with diabetes mellitus or renal impairment. Centre B had a significantly higher percentage of patients with an urgent or emergency first procedure within the study period (36 versus 25 per cent, p < 0.001).
Lesion characteristics (Table 3)
During the period of the study, the 445 patients at centre A had 482 vessels treated while the 601 patients at centre B had 715 initial procedures on separate vessels. The anatomical distribution of vessels treated at each centre was similar [left anterior descending artery (LAD) 42.5 versus 39.8 per cent]. Centre B also treated vessels with a significantly more adverse American Heart Association score ( 
Costs of PCI
The costs associated with 200 cases were examined in detail (Table 4 ). There was a significant difference (t-test, p < 0.001) in the total cost of the 100 cases between the centres with centre B having the higher total cost (95 per cent CI for difference: £477-£847).
In all cases (100 per cent), standard equipment, standard medication, wires, guides, contrast and staff costs made up 20 per cent or less of the total procedure cost. This suggests that these items are of less importance in terms of overall procedural cost. Stents, length of stay (bed-days) and balloons contributed 20 per cent or more of the total cost in 84, 30, 21 per cent of procedures respectively, and therefore represent the main cost drivers. The cost of individual components was similar between the centres as the same standard equipment, standard medication and grades of staff were used. However, whilst the wires and guides made up a relatively small proportion of the total cost, their use differed between the centres. On average, centre B used more wires (mean 1.56 versus 1.21; Mann-Whitney U test, p ϭ 0.002) and more guides (mean 1.36 versus 1.13, p ϭ 0.007) per procedure than centre A. Although there was no significant difference in the number of balloons used for non-stented procedures (1.79 versus 1.60, p ϭ 0.84), the mean number of balloons for non-stented procedures for each centre was used in the calculation as balloon-use was a main cost driver. Details of the calculation for the cost of the retrospective procedures are given in Table 1 .
Retrospective analysis of cost of procedures (Table 4)
Considering all 1158 procedures within the study period (first and repeat procedures), stents were used in a significantly higher number of procedures at centre B (56 versus 26 per cent; 2 test, p < 0.001). There were significantly more urgent cases at centre B (38 versus 26 The costs were substantially different between the two centres for routine and for urgent cases. This was accounted for predominantly by a greater use of stents and a greater number of vessels treated per patient at centre B. Additionally, the number of bed-days was higher for centre B due to a higher proportion of urgent cases which were more costly in terms of bed-days (Table 4) . Left ventricular function, renal impairment, diabetes mellitus and age were significant independent predictors of death within the study period (Table 6) .
Examining case-mix-adjusted outcomes for all 1158 PCI procedures, using a stepwise Cox regression model, decreasing vessel size, severity of angina and hypertension were associated with a shorter time to repeat target vessel PCI. Interventional centre was not a statistically significant predictor of repeat PCI (p ϭ 0.15) after adjusting for age, sex, smoking status, Carstair's deprivation score, angina score (CCS), urgency of procedure, minimum vessel size, presence of diabetes, hypertension, peripheral arterial disease, carotid stenosis, renal impairment, previous cardiac surgery, previous myocardial infarction and previous PCI. The only factor that significantly (p ϭ 0.002) predicted subsequent coronary artery bypass graft surgery was the presence of diabetes (hazard ratio: 2.81; 95 per cent CI: 1.47-5.37).
Discussion
This study explored and compared the costs and outcomes of PCI performed in a routine clinical setting in two university teaching hospitals. There were significant differences in the use of stents and this was reflected in a substantial difference in costs of PCI. When crude outcome data were considered there was a trend towards worse outcomes at the centre with increased costs and greater use of stents. However, after case-mix-adjusted analysis it became clear that this interventional centre performed PCI on patients with more severe and complex disease, smaller vessels and in patients with a more adverse cardiovascular risk profile. These differences explain the trend towards increased cost and poorer outcomes of death and revascularization.
Influence of case-mix on outcomes
Patients who were older, had urgent procedures, higher angina scores (CCS), increased severity of coronary artery disease, more severe left ventricular function, diabetes mellitus and renal impairment had a significantly shorter time to death (when examined univariately). For all except the latter two factors, patients treated at centre B were significantly worse in terms of these characteristics. So, it is not unexpected that centre B had a higher crude death rate.
Urgent procedures, higher angina scores (CCS), hypertension, carotid stenosis, decreased vessel size, less deprivation and non-smoking were significant univariate factors in Cox regression when examining repeat PCI on the same vessel. No significant differences in smoking status occurred between the centres but centre B had more adverse risk for all the remaining cardiovascular risk factors. These differences can go some way to explaining the significant difference in target vessel 
Influence of lesion characteristics on outcomes
The need for repeat target vessel PCI was significantly greater at centre B. There was no significant difference in the type of vessel treated and centre B demonstrated a consistently greater need for repeat revascularization for all vessel territories. There was also no significant difference in the length of stents used implying that overall there was no difference in lesion length between centres. The higher rate of repeat PCI at centre B was therefore due to significantly smaller diameter vessels and increased complexity of lesion by AHA criteria. This is consistent with other data from randomized trials of stents 15, 16 and other PCI registries. [17] [18] [19] Less complex lesion morphology combined with larger vessels at centre A may have contributed to the very low rate of repeat target vessel PCI (5.6 per cent). However, although the crude 12 month target vessel re-intervention rate was significantly higher at centre B, the absolute rate of reintervention (10.3 per cent per annum) compares well with randomized trials 15 and other registry data 17 , despite the adverse cardiovascular risk profile in patients from this centre.
Costs of percutaneous coronary intervention
Few previous studies have accurately calculated the procedural costs of routine and urgent PCI outside the context of randomized clinical trials. The average procedure related cost in our study was £1970 at centre B and £1521 at centre A. This difference was accounted for mainly by a difference in the use of stents. Some of the difference in cost was also related to a greater number of vessels treated per patient at centre B but the cost per vessel was also 25 per cent higher at centre B (Table 4) . The overall cost per patient was also higher at centre B because of the greater need for repeat PCI at this centre. Examining costs overall, urgent cases were significantly more expensive than routine cases at both centres. This is an important finding given that an increasing proportion of interventional workload is now urgent in-patient activity driven by more widespread use of troponin assays in risk stratification. 20 The greater costs for urgent procedures resulted predominantly from a longer length of hospital stay in these patients. Future financial planning for interventional services will need to take account of this difference in cost between urgent and routine cases.
Our study confirms that performing PCI on patients with a more adverse risk profile will result in a relatively higher repeat PCI rate and will be significantly more expensive. The repeat target vessel PCI rate at centre A with lower risk patients, larger vessels and less complex disease (by AHA classification) is low and suggests that this strategy may be relatively inexpensive.
Study limitations
This study has a number of important limitations. First, the data were collected in 1997-1998 and interventional practice has changed since that time. Stent use has now become more widespread and the cost of equipment has reduced significantly. Registry data were collected prospectively on a clinical database and were reviewed retrospectively. As far as possible clear definitions were used during the prospective collection of data but there may have been differences between clinicians, technicians and nurses entering the data. The costs were calculated retrospectively making assumptions about the use of equipment and standardizing costs between the two centres.
Despite these issues our findings have important implications for the dissemination of outcome data into the public arena. There are major concerns about such a strategy expressed by healthcare professionals and the public. 6 The aims are to improve quality of care and accountability but there are risks that it may engender poor morale for clinicians and unnecessary anxiety for patients. 3 Furthermore, there is little evidence that releasing such outcome data has any effect on performance. Death rates associated with cardiac surgery reduced in the United States after release of outcome data into the public domain in some states 21 but it has also improved in regions where it was not released. 22 Concerns among cardiac surgeons has resulted in increased reporting of co-morbidities and difficulties in finding surgeons to undertake high-risk procedures. 23 A similar response could await widespread publication of outcomes for PCI.
Conclusions
Our study highlights the problems of analysing raw mortality and revascularization rates while not taking account of important differences in case-mix. Differences in mortality and morbidity following PCI between centres is influenced greatly by disease severity and pre-procedural risk factor status. This reaffirms the need for all interventional centres to collect detailed data on case-mix along with short-and long-term outcomes of interventional procedures. If we are to disseminate outcome data of interventional procedures to the public then it should be accompanied by rigorous case-mix analysis.
This study also suggests that plans for expansion of PCI should not be calculated on a simple per case basis but should incorporate additional costs for increasingly complex multivessel procedures.
